Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes

被引:28
作者
Skovso, S. [1 ]
Damgaard, J. [2 ]
Fels, J. J. [2 ]
Olsen, G. S. [2 ]
Wolf, X. A. [2 ]
Rolin, B. [2 ]
Holst, J. J. [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Endocrinol Res Sect, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
[2] Novo Nordisk A S, Diabet Res Unit, Malov, Denmark
关键词
BODY-FAT; ADIPOSE-TISSUE; RISK-FACTOR; NPH INSULIN; OBESITY; RECEPTOR; PARTICIPANTS; ADIPONECTIN; DETERMINANT; CHOLESTEROL;
D O I
10.1038/ijo.2015.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND/OBJECTIVES: Insulin therapy is required for many patients with the obesity-related disorder type 2 diabetes, but is also associated with weight gain. The specific location of adipose tissue location matters to cardiovascular disease (CVD) risk. We investigated effects of exogenous insulin on fat distribution in the high-fat/high-sucrose fed rat treated with streptozotocin (HF/HS-STZ) rat model of type 2 diabetes. We also examined effects of insulin therapy on circulating CVD markers, including adiponectin, triglycerides (TGs), total cholesterol and high-density lipoprotein. SUBJECTS/METHODS: Male SD rats were HF/HS fed for 5 weeks followed by STZ treatment to mimic the hallmarks of human obesity-associated insulin resistance followed by hyperglycemia. Magnetic resonance imaging and computed tomography were used to determine total fat, abdominal fat distribution and liver fat before and after insulin therapy in HF/HS-STZ rats. HbA1c%, TGs, cholesterol, high-density lipoprotein and adiponectin were analyzed by conventional methods adapted for rats. RESULTS: Insulin therapy lowered HbA1c (P<0.001), increased body weight (P<0.001), increased lean mass (P<0.001) and led to a near doubling of total fat mass (P<0.001), with the highest increase in subcutaneous adipose tissue as compared with visceral adipose tissue (P<0.001). No changes in liver fat were observed after insulin therapy, whereas plasma TG and cholesterol levels were decreased (P<0.001, P<0.01), while high-density lipoprotein (HDL) and adiponectin levels were elevated (P<0.01, P<0.001). CONCLUSIONS: Using the HF/HS-STZ rat as an animal model for type 2 diabetes, we find that insulin therapy modulates fat distribution. Specifically, our data show that insulin has a relatively positive effect on CVD-associated parameters, including abdominal fat distribution, lean body mass, adiponectin, TGs and HDL in HF/HS-STZ rats, despite a modest gain in weight.
引用
收藏
页码:1531 / 1538
页数:8
相关论文
共 47 条
  • [1] Standards of Medical Care in Diabetes-2014
    不详
    [J]. DIABETES CARE, 2014, 37 : S14 - S80
  • [2] [Anonymous], 2014, IDF Diabetes Atlas, VSixth
  • [3] Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes Real-world diabetes therapy in a clinical trial cohort
    Best, James D.
    Drury, Paul L.
    Davis, Timothy M. E.
    Taskinen, Marja-Riitta
    Kesaniemi, Y. Antero
    Scott, Russell
    Pardy, Christopher
    Voysey, Merryn
    Keech, Anthony C.
    [J]. DIABETES CARE, 2012, 35 (05) : 1165 - 1170
  • [4] DIFFERENCES AT THE RECEPTOR AND POSTRECEPTOR LEVELS BETWEEN HUMAN OMENTAL AND SUBCUTANEOUS ADIPOSE-TISSUE IN THE ACTION OF INSULIN ON LIPOLYSIS
    BOLINDER, J
    KAGER, L
    OSTMAN, J
    ARNER, P
    [J]. DIABETES, 1983, 32 (02) : 117 - 123
  • [5] Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzer
    Conde-Sanchez, Manuel
    Roldan-Fontana, Esther
    Chueca-Porcuna, Natalia
    Pardo, Susana
    Porras-Gracia, Juan
    [J]. CLINICAL BIOCHEMISTRY, 2010, 43 (10-11) : 921 - 925
  • [6] Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia
    Davies, Melanie J.
    Derezinski, Tadeusz
    Pedersen, Claus Bang
    Clauson, Per
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (04) : 273 - 277
  • [7] Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels
    Demerath, Ellen W.
    Reed, Derek
    Rogers, Nikki
    Sun, Shumei S.
    Lee, Miryoung
    Choh, Audrey C.
    Couch, William
    Czerwinski, Stefan A.
    Chumlea, W. Cameron
    Siervogel, Roger M.
    Towne, Bradford
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (05) : 1263 - 1271
  • [8] Elsayed A, 2007, PAK J MED SCI, V23, P161
  • [9] Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein
    Erion, Derek M.
    Ignatova, Irena D.
    Yonemitsu, Shin
    Nagai, Yoshio
    Chatterjee, Paula
    Weismann, Dirk
    Hsiao, Jennifer J.
    Zhang, Dongyan
    Iwasaki, Takanori
    Stark, Romana
    Flannery, Clare
    Kahn, Mario
    Carmean, Christopher M.
    Yu, Xing Xian
    Murray, Susan F.
    Bhanot, Sanjay
    Monia, Brett P.
    Cline, Gary W.
    Samuel, Varman T.
    Shulman, Gerald I.
    [J]. CELL METABOLISM, 2009, 10 (06) : 499 - 506
  • [10] Impact of overweight on the risk of developing common chronic diseases during a 10-year period
    Field, AE
    Coakley, EH
    Spadano, JL
    Laird, N
    Dietz, WH
    Rimm, E
    Colditz, GA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1581 - 1586